Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma SamplesBroderick C. Corless, David Polsky, Gregory Chang et al.|Journal of Molecular Diagnostics|2018Cited by 69
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma TumorsGregory Chang, David Polsky, Jennifer Wiggins et al.|Journal of Investigative Dermatology|2020Cited by 22
Plasma cell-free circulating tumor DNA (ctDNA) detection in longitudinally followed glioblastoma patients using <i>TERT</i> promoter mutation-specific droplet digital PCR assays.Christine Cordova, John G. Golfinos, Jessica Schafrick et al.|Journal of Clinical Oncology|2019Cited by 12
Prediction of breast cancer risk based on flow-variant analysis of circulating peripheral blood B cellsMahrukh M. Syeda, Harry Ostrer, Kinnari Upadhyay et al.|Genetics in Medicine|2017Cited by 4
Abstract 5534: Analysis of <i>TERT</i> <i>mutant</i> circulating tumor DNA as a potential biomarker of disease activity in patients with unresectable stage III/IV melanoma receiving immuno-oncology therapiesMahrukh M. Syeda, David Polsky, Melissa Wilson et al.|Cancer Research|2018Cited by 1